An official website of the United States government
Home
Name
PD 0332991
Alternate Names
PD 991
Abbreviations
None
Category
Chemotherapy
Subcategory
investigational cell-cycle inhibitor
NSC Number
None
Primary Site
ER positive/ HER2-negative breast cancer
Histology
None
Remarks
Currently in trials. This drug is being used in combination with the aromatase inhibitor letrozole (Femara) to treat women with advanced breast cancer.
Coding
This drug should be coded
